TWiV 692: COVID-19 clinical update #40 with Dr. Daniel Griffin

December 11, 2020

Daniel Griffin provides his weekly clinical report on COVID-19, including the anticipated EUA for the Pfizer mRNA vaccine, mitigation strategies in early care and education settings, expressive aphasia, and much more.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 692 (23 MB .mp3, 38 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your virology questions and comments to

Leave a Reply

Your email address will not be published. Required fields are marked *

One comment on “TWiV 692: COVID-19 clinical update #40 with Dr. Daniel Griffin

  1. During the FDA VRBPAC meeting to decide on an EUA yesterday, two committee members asked at different times about whether it was possible for the modified mRNA in the Pfizer-BioNTech COVID-19 vaccine to be reverse transcribed by cellular or retroviral reverse transcriptases. The first time, the answer was that there was a very low probability of that happening (though not much further explanation), and the second time, the question was ignored. Could you please comment or bring on another expert next time to explain what exactly is known about this possibility? Would very much appreciate it as this has been very much on my mind since then.